Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,850 JPY | -0.51% | +0.79% | +5.12% |
04:23am | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
Apr. 15 | Neumora's early-stage schizophrenia drug study put on hold | RE |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- This company will be of major interest to investors in search of a high dividend stock.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The group shows a rather high level of debt in proportion to its EBITDA.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Wireless Telecommunications Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.12% | 56.93B | A- | ||
+29.35% | 95.31B | C+ | ||
-12.62% | 23.42B | A- | ||
-16.75% | 20.52B | C | ||
+5.61% | 10.65B | C | ||
-13.12% | 10.45B | C | ||
+0.49% | 10.04B | B+ | ||
+0.75% | 8.89B | B+ | ||
+19.66% | 6.63B | B | ||
-.--% | 5.15B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 9434 Stock
- Ratings SoftBank Corp.